Join Paid Clinical Trials for Cystic Fibrosis in

Paid Clinical Trials and Focus Groups


Find Paid Clinical Trials

Paid Clinical Trials - : Cystic Fibrosis

Top of Directory » All Categories » by Illness » Cystic Fibrosis



  • Building Adherence to Live With And Navigate my Cystic Fibrosis (CF) Experience

    Condition:   Cystic Fibrosis
    Intervention:   Behavioral: Motivational Interviewing
    Sponsors:   Johns Hopkins University;   National Heart, Lung, and Blood Institute (NHLBI)
    Recruiting - verified November 2009
  • A Study of CellCept (Mycophenolate Mofetil) in Lung Transplant Recipients

    Condition:   Lung Transplantation
    Intervention:   Drug: mycophenolate mofetil [CellCept]
    Sponsor:   Hoffmann-La Roche
    Not yet recruiting - verified November 2009
  • Does a Nasal Instillation of Vardenafil Normalize the Nasal Potential Difference in Cystic Fibrosis Patients?

    Condition:   Cystic Fibrosis
    Interventions:   Drug: Vardenafil;   Drug: Placebo
    Sponsor:   Cliniques universitaires Saint-Luc- Université Catholique de Louvain
    Not yet recruiting - verified October 2009
  • A Randomized, Double-Blind, Placebo-Controlled Multiple Dose Trial of GS-9411 in Healthy Volunteers

    Conditions:   Cystic Fibrosis;   Mucociliary Clearance;   Airway Hydration
    Interventions:   Drug: GS-9411;   Drug: Placebo
    Sponsor:   Gilead Sciences
    Recruiting - verified November 2009
  • Efficacy and Safety of ONCOXIN in Patients With Breast Fibrocystic Disease

    Condition:   Breast Fibrocystic Disease
    Interventions:   Dietary Supplement: Oncoxin;   Dietary Supplement: Placebo
    Sponsor:   Catalysis SL
    Recruiting - verified November 2009
  • Study of VX-770 in Cystic Fibrosis Subjects Age 12 and Older Homozygous for the F508del-CFTR Mutation

    Condition:   Cystic Fibrosis
    Interventions:   Drug: VX-770;   Drug: Placebo
    Sponsors:   Vertex Pharmaceuticals Incorporated;   Cystic Fibrosis Foundation
    Recruiting - verified November 2009
  • Oral Docosahexanoic Acid Supplementation in Cystic Fibrosis

    Condition:   Cystic Fibrosis
    Interventions:   Dietary Supplement: Docosahexanoic Acid Supplement;   Dietary Supplement: Placebo
    Sponsor:   Vanderbilt University
    Recruiting - verified October 2009
  • Study of VX-770 in Cystic Fibrosis Subjects Age 12 and Older With the G551D Mutation

    Condition:   Cystic Fibrosis
    Interventions:   Drug: VX-770;   Drug: Placebo
    Sponsors:   Vertex Pharmaceuticals Incorporated;   Cystic Fibrosis Foundation
    Recruiting - verified November 2009
  • Study of VX-770 in Cystic Fibrosis Subjects Age 6 to 11 With the G551D Mutation

    Condition:   Cystic Fibrosis
    Interventions:   Drug: VX-770;   Drug: Placebo
    Sponsors:   Vertex Pharmaceuticals Incorporated;   Cystic Fibrosis Foundation
    Recruiting - verified November 2009
  • Evaluation of Bronchial Inflammation in Allergic Bronchopulmonary Aspergillosis (ABPA)

    Conditions:   Cystic Fibrosis;   Allergic Bronchopulmonary Aspergillosis
    Intervention:  
    Sponsor:   Johann Wolfgang Goethe University Hospitals
    Recruiting - verified October 2009
  • 28 Day Repeat Dose in Cystic Fibrosis Patients

    Condition:   Cystic Fibrosis
    Interventions:   Drug: SB656933;   Drug: Placebo;   Drug: SB656933
    Sponsor:   GlaxoSmithKline
    Recruiting - verified November 2009
  • N-acetylcysteine (NAC): A Multi-Center, Phase IIB, Randomized, Placebo-controlled, Double-Blind Study Of The Effects Of N-Acetylcysteine On Redox Changes and Lung Inflammation In Cystic Fibrosis Patients

    Condition:   Cystic Fibrosis
    Intervention:   Drug: N-acetylcysteine (NAC)
    Sponsors:   Stanford University;   Cystic Fibrosis Foundation
    Recruiting - verified October 2009
  • Study of Ataluren (PTC124™) in Cystic Fibrosis

    Condition:   Cystic Fibrosis
    Interventions:   Drug: Ataluren (PTC124);   Drug: Placebo
    Sponsors:   PTC Therapeutics;   Genzyme;   Cystic Fibrosis Foundation
    Recruiting - verified November 2009
  • Cystic Fibrosis (CF) Leukocyte Genes as Biomarkers for Novel Therapies

    Conditions:   Cystic Fibrosis;   Pulmonary Exacerbation
    Intervention:  
    Sponsors:   National Jewish Health;   Cystic Fibrosis Foundation
    Recruiting - verified October 2009
  • Infant Study of Inhaled Saline in Cystic Fibrosis

    Condition:   Cystic Fibrosis
    Interventions:   Drug: 7% Hypertonic Saline (HS);   Drug: 0.9% Isotonic Saline (IS)
    Sponsors:   CF Therapeutics Development Network Coordinating Center;   Cystic Fibrosis Foundation;   National Heart, Lung, and Blood Institute (NHLBI)
    Recruiting - verified November 2009
    • Menu
    Find Paid Clinical Trials